Point-of-care Arkansas method for measuring adherence to treatment with isoniazid

Respiratory Medicine

Volumn 104, Issue 5, 2010, Pages 754-757

  Guerra, Renata L ^a   Conde, Marcus B ^a   Efron, Anne ^b   Loredo, Carla ^a   Bastos, Gisele ^a   Chaisson, Richard E ^b   Golub, Jonathan E ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adherence; Arkansas method; Isoniazid; Latent tuberculosis infection

Indexed keywords

DRUG METABOLITE; ISONIAZID; TOBACCO SMOKE; TUBERCULOSTATIC AGENT;

ACCURACY; ADULT; ARTICLE; ASSAY; BRAZIL; CHEMOPROPHYLAXIS; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; POINT OF CARE TESTING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SMOKING; TUBERCULOSIS; FEMALE; MALE; MEDICATION COMPLIANCE; TUBERCULOSIS, PULMONARY; URINE;

ADULT; ANTITUBERCULAR AGENTS; BRAZIL; FEMALE; HUMANS; ISONIAZID; MALE; MEDICATION ADHERENCE; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, PULMONARY;

EID: 77951622711     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2010.02.001     Document Type: Article

References (11)

1. Churchyard G., Fielding K., Charalambous S., et al. Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy?. AIDS 17 14 (2003) 2063-2070
2. American Thoracic Society. Targeted tuberculosis testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 161 (2000) 5221-5247
3. Schraufnagel D.E., Stoner R., Whiting E., Snukst-Torbeck G., and Werhane M.J. Testing for isoniazid. An evaluation of the Arkansas method. Chest 98 2 (1990) 314-316
4. Elizaga J., and Friedland J.S. Monitoring compliance with antituberculous treatment by detection of isoniazid in urine. Lancet 350 (1997) 1225-1226
5. Perry S., Hovell M.F., Blumberg E., et al. Urine testing to monitor adherence to TB preventive therapy. J Clin Epidemiol 55 (2002) 235-238
6. Eidlitz-Markus T., Zeharia A., Baum G., Mimouni M., and Amir J. Use of the urine color test to monitor compliance with isoniazid treatment of latent tuberculosis infection. Chest 123 (2003) 736-739
7. Whitfield R., and Cope G.F. Point-of-care test to monitor adherence to anti-tuberculosis treatment. Ann Clin Biochem 41 (2004) 411-413
8. Moulton L.H., Golub J.E., Durovni B., et al. Statistical design of THRio: a phased implementation clinic-randomized study of a tuberculosis preventive therapy intervention. Clin Trials 4 2 (2007) 190-199
9. White M.C., Tulsky J.P., Reilly P., McIntosh H.W., Hoynes T.M., and Goldenson J. A clinical trial of a financial incentive to go to the tuberculosis clinic for isoniazid after release from jail. Int J Tuberc Lung Dis 2 (1998) 506-512
10. Ellard G.A., Jenner P.J., and Downs P.A. An evaluation of the potential use of isoniazid, acetylisoniazid and isonicotinic acid for monitoring the self-administration of drugs. Br J Clin Pharmacol 10 (1980) 369-381
11. Hanifa Y., Mngadi K., Lewis J., Fielding K., Churchyard G., and Grant A.D. Evaluation of the Arkansas method of urine testing for isoniazid in South Africa. Int J Tuberc Lung Dis 11 (2007) 1232-1236